CoChat

Translating 5‐HT4receptor pharmacology

Open access
Sanger, G. J. · 2009 · Neurogastroenterology & Motility
Cited by 54

The DOI matches its Crossref record.

Abstract

Since metoclopramide was first described (in 1964) there have been several attempts to develop compounds which retained gastrointestinal prokinetic activity (via 5‐HT 4 receptor activation) but without the limiting side effects associated with dopamine D 2 receptor antagonism. Early compounds (mosapride, cisapride, renzapride, tegaserod) were identified before several of the 5‐HT receptors were even described (including 5‐HT 4 and 5‐HT 2B), whereas prucalopride came later. Several compounds were hampered by non‐selectivity, introducing cardiac liability (cisapride: activity at human Ether‐a‐go‐go Related Gene) or potentially, a reduced intestinal prokinetic activity caused by activity at a second 5‐HT receptor (renzapride: antagonism at the 5‐HT 3 receptor; tegaserod: antagonism at the 5‐HT 2B receptor). Poor intrinsic activity at gastrointestinal 5‐HT 4 receptors has also been an issue (mosapride, tegaserod). Perhaps prucalopride has now achieved the profile of good selectivity of action and high intrinsic activity at intestinal 5‐HT 4 receptors, without clinically‐meaningful actions on 5‐HT 4 receptors in the heart. The progress of this compound for treatment of chronic constipation, as well as competitor molecules such as ATI‐7505 and TD‐5108, will now be followed with interest as each attempts to differentiate themselves from each other. Perhaps at last, 5‐HT 4 receptor agonists are being given the chance to show what they can do.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2982.2009.01425.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 54

Metadata

Authors
Sanger, G. J.
Venue
Neurogastroenterology & Motility
Publisher
Wiley
Published
2009-11-10
Volume
21
Issue
12
Pages
1235-1238
ISSN
  • 1350-1925 (ISSN-L)
  • 1365-2982
OpenAlex
W1522676737
Cited by
54
References
0
FWCI
6.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Translating 5‐HT4receptor pharmacology. https://app.cochat.ai/papers/10.1111/j.1365-2982.2009.01425.x
The paper
Sanger, G. J. (2009). Translating 5‐HT4receptor pharmacology. Neurogastroenterology & Motility. https://doi.org/10.1111/j.1365-2982.2009.01425.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.